Physician profile
Robert T Trousdale
NPI 1972582344
$12,173,035.64
in general payments reported to CMS, 2019-2025
8 companies · $1.9M in 2025
The $1.9M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1.4M · 2020: $1.6M · 2021: $2.0M · 2022: $1.9M · 2023: $1.7M · 2024: $1.7M · 2025: $1.9M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $5.3M · Consulting Fee: $26K · Travel and Lodging: $3,034 · Food and Beverage: $719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $5,279,677.79 |
| Consulting Fee | $25,901.15 |
| Travel and Lodging | $3,034.42 |
| Food and Beverage | $718.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $12,076,519.68 | 2019-2025 | Attune, Reclaim, Pinnacle Gription Tf |
| Restor3d, INC. | $48,111.83 | 2024-2025 | |
| Medical Device Business Services, INC. | $25,040.95 | 2019-2025 | Attune, Velys |
| Conformis, INC. | $18,006.80 | 2021-2023 | Actera Hip Stem |
| Medtronic USA, INC. | $1,875.00 | 2019 | |
| Smith+Nephew, INC. | $1,521.34 | 2023 | Real Intelligence, Ri Hip Navigation, Visionaire |
| Depuy Synthes Sales INC. | $1,185.40 | 2019-2023 | Attune |
| Ortho Development Corporation | $774.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Trousdale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.